カテゴリ： MarketLine, アメリカ, 企業調査

Kimberly-Clark Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：Kimberly-Clark Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3804
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：57
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Kimberly-Clark Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Kimberly-Clark Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Kimberly-Clark Corporation (Kimberly-Clark) is a global hygiene company, involved in manufacturing and marketing of personal care and house hold products. The company’s products portfolio includes disposable diapers; baby wipes; paper towels; facial and bathroom tissues; napkins; training and youth pants; and swim pants. It also provides apparel, soaps, sanitizers, and feminine and incontinence care products. Kimberly-Clark markets these products under various brands such as Kleenex, Scott, Huggies, Little Swimmers, U by Kotex, Pull-Ups, Kotex, Depend, and others. The company operates in North America, Europe, Middle East and Africa, Asia, and Latin America. Kimberly-Clark is headquartered in Irving, Texas, the US.

Scope

- Detailed information on Kimberly-Clark Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kimberly-Clark Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Kimberly-Clark Corporation including a breakdown and examination of key business segments
- Intelligence on Kimberly-Clark Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kimberly-Clark Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Kimberly-Clark Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kimberly-Clark Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Kimberly-Clark Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Kimberly-Clark Corporation: Company Overview 9
Kimberly-Clark Corporation: Overview and Key Facts 9
Kimberly-Clark Corporation: Overview 9
Kimberly-Clark Corporation: Key Facts 9
Kimberly-Clark Corporation: Key Employees 11
Kimberly-Clark Corporation: Key Employee Biographies 13
Kimberly-Clark Corporation: Major Products and Services 21
Kimberly-Clark Corporation: Company History 23
Kimberly-Clark Corporation: Management Statement 30
Kimberly-Clark Corporation: Locations and Subsidiaries 32
Kimberly-Clark Corporation: Key Competitors 34
Kimberly-Clark Corporation: Company Analysis 35
Kimberly-Clark Corporation: Business Description 35
Kimberly-Clark Corporation: SWOT Analysis 36
Kimberly-Clark Corporation: SWOT Overview 36
Kimberly-Clark Corporation: Strengths 36
Kimberly-Clark Corporation: Weaknesses 37
Kimberly-Clark Corporation: Opportunities 37
Kimberly-Clark Corporation: Threats 38
Kimberly-Clark Corporation: Corporate Financial Deals Activity 40
Kimberly-Clark Corporation: Financial Deals Overview 40
Kimberly-Clark Corporation: Targets and Partners 42
Kimberly-Clark Corporation: Top Deals 2014 – 2018YTD* 43
Kimberly-Clark Corporation: Advisors 44
Kimberly-Clark Corporation: Top Legal Advisors 44
Kimberly-Clark Corporation: Mergers and Acquisitions 45
Kimberly-Clark Corporation: Divestments 46
Kimberly-Clark Corporation: Recent Developments 47
Kimberly-Clark Corporation: News and Events Summary 47
Kimberly-Clark Corporation: Business Expansion 50
Kimberly-Clark Corporation: Business Reorganization 51
Kimberly-Clark Corporation: Corporate Governance 52
Kimberly-Clark Corporation: Financial Deals 52
Kimberly-Clark Corporation: Financial Performance 53
Kimberly-Clark Corporation: Red Flags/Distress Signals 53
Kimberly-Clark Corporation: Red Flags/DistressSignals 54
Appendix 55
Contact Us 55
Methodology 55
About MarketLine 56

List of Tables
Table 1: Kimberly-Clark Corporation: Key Facts
Table 2: Kimberly-Clark Corporation: Key Employees
Table 3: Kimberly-Clark Corporation: Locations and Subsidiaries
Table 4: Kimberly-Clark Corporation: Key Competitors
Table 5: Kimberly-Clark Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Kimberly-Clark Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Kimberly-Clark Corporation: M&A Average Deal Size - Value (US$m)
Table 8: Kimberly-Clark Corporation: Targets and Partners
Table 9: Kimberly-Clark Corporation: Top Deals 2014 - 2018YTD*
Table 10: Kimberly-Clark Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: Kimberly-Clark Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Kimberly-Clark Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Kimberly-Clark Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Kimberly-Clark Corporation: News and Events Summary
Table 15: Kimberly-Clark Corporation: Business Expansion
Table 16: Kimberly-Clark Corporation: Business Reorganization
Table 17: Kimberly-Clark Corporation: Corporate Governance
Table 18: Kimberly-Clark Corporation: Financial Deals
Table 19: Kimberly-Clark Corporation: Financial Performance
Table 20: Kimberly-Clark Corporation: Red Flags/Distress Signals
Table 21: Kimberly-Clark Corporation: Red Flags/DistressSignals

List of Figures
Figure 1: Kimberly-Clark Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Kimberly-Clark Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Kimberly-Clark Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Kimberly-Clark Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Kimberly-Clark Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Kimberly-Clark Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Kimberly-Clark Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CardioDx Inc：医療機器：M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • Fidelidade – Companhia de Seguros, S.A.：企業の戦略・SWOT・財務情報
    Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report Summary Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Erste Group Bank AG：企業の戦略・SWOT・財務分析
    Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report Summary Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ceapro Inc (CZO)-製薬・医療分野：企業M&A・提携分析
    Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and ani …
  • Hoya Corporation：企業の戦略・SWOT・財務情報
    Hoya Corporation - Strategy, SWOT and Corporate Finance Report Summary Hoya Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Acino International AG：企業の戦略的SWOT分析
    Acino International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Selecta Biosciences Inc (SELB)：企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Kenzo Parfums NA, LLC：企業の戦略・SWOT・財務情報
    Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Amazon.com Inc (AMZN)：企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aster DM Healthcare (ASTERDM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as mobile medical units, cardiac surgery, early cancer detection centers, village adoption, and dialys …
  • Microbix Biosystems Inc (MBX)：企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野：企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • T2 Biosystems Inc (TTOO)：企業の製品パイプライン分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle …
  • Alteogen Inc (196170)：製薬・医療：M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • ComOps Limited (COM)：企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PPL Corporation：企業の戦略・SWOT・財務情報
    PPL Corporation - Strategy, SWOT and Corporate Finance Report Summary PPL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PHX Minerals Inc (PHX)：企業の財務・戦略的SWOT分析
    PHX Minerals Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Leaf Clean Energy Company (LEAF)：企業の財務・戦略的SWOT分析
    Summary Leaf Clean Energy Company (Leaf Clean Energy) is a provider of renewable energy and sustainable technology investments. It offers growth and venture capital across the renewable energy industry to support novelty, well-managed and rapidly-growing companies. It operates and manages energy pro …
  • Fluor Corporation (FLR)-エネルギー分野：企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆